Baseline ventilatory function predicts the development of higher levels of fasting insulin and fasting insulin resistance index: The Normative Aging Study

European Respiratory Journal

Volumn 12, Issue 3, 1998, Pages 641-645

  Lazarus, R ^a,b   Sparrow, D ^c   Weiss, S T ^b  

^a University of Sydney   (Australia)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Coronary disease; Insulin resistance; Prospective study; Serum insulin levels; Spirometry

Indexed keywords

ADULT; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CIGARETTE SMOKING; DIET RESTRICTION; FORCED EXPIRATORY VOLUME; GLUCOSE INTOLERANCE; HUMAN; HUMAN EXPERIMENT; INSULIN RESISTANCE; MALE; MORTALITY; NORMAL HUMAN; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RESPIRATORY FUNCTION; SPIROMETRY;

ADULT; AGED; AGED, 80 AND OVER; AGING; BLOOD GLUCOSE; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); CORONARY DISEASE; CROSS-SECTIONAL STUDIES; FASTING; FORCED EXPIRATORY VOLUME; HUMANS; INSULIN; INSULIN RESISTANCE; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; VITAL CAPACITY;

EID: 0031716151     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.98.12030641     Document Type: Article

References (32)

1. Friedman G, Klatsky A, Siegelaub M. Lung function and risk of myocardial infarction and sudden cardiac death. N Engl J Med 1976; 294: 1071-1075.
2. Kannel W, Hubert H, Lew E. Vital capacity as a predictor of cardiovascular disease: the Framingham study. Am Heart J 1983; 105: 311-315.
3. Persson C, Bengtsson C, Lapidus L, Rybo E, Thringer G, Wedel H. Peak expiratory flow rate and risk of cardiovascular disease and death: a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Am J Epidemiol 1986; 124: 942-948.
4. Lange P, Nyboe J, Jensen G, Schnohr P, Appleyard M. Ventilatory function impairment and risk of cardiovascular death and of fatal or non-fatal myocardial infarction. Eur Respir J 1991; 4: 1080-1087.
5. Beaty T, Cohen B, Newill C, Menkes H, Diamond E, Chen C. Impaired pulmonary function as a risk factor for mortality. Am J Epidemiol 1982; 116 (1): 102-113.
6. Marcus E, Buist S, Curb D, et al. Correlates of FEV1 and prevalence of pulmonary conditions in Japanese-American men. Thorax 1988; 138: 1398-1404.
7. Lange P, Groth S, Kastrup J, et al. Diabetes mellitus, plasma glucose and lung function in a cross-sectional population study. Eur Respir J 1989; 2: 14-19.
8. Burchfiel C, Curb D, Sharp D, et al. Distribution and correlates of insulin in elderly men: the Honolulu heart program. Arterioscl Thromb Vasc Biol 1995; 15: 2213-2221.
9. Lange P, Groth S, Mortensen J, et al. Diabetes mellitus and ventilatory capacity: a five year follow-up study. Eur Respir J 1990; 3: 288-292.
10. Hall J, Summers R, Brands M, Keen H, Alonso-Galicia M. Resistance to the metabolic actions of insulin and its role in hypertension. Am J Hypertens 1994; 7: 772-788.
11. DeFronzo R, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care 1991;14: 173-194.
12. Bell B, Rose C, Damon H. The normative aging study: an interdisciplinary and longitudinal study of health and aging. Aging Hum Dev 1972; 3: 5-17.
13. Willett W. Anthropometric measures and body composition. In: MacMahon B, ed. Nutritional Epidemiology, 1st Edn. Monographs in Epidemiology and Biostatistics, Vol. 15, New York, Oxford University Press, 1990; pp. 217-244.
14. Kory R, Callahan R, Boren H, Syner J. The Vererans Administration-Army Cooperative Study of Pulmonary Function: I. Clinical spirometry in normal men. Am J Med 1961; 30: 243-258.
15. Duncan MH, Singh BM, Wise PH, Carter G. A simple measure of insulin resistance. Lancet 1995; 346: 120-121.
16. Mathews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
17. World Health Organization. Diabetes mellitus. Report of a WHO study group. Geneva, World Health Organization, 1985; Technical Report Series 727.
18. SAS Institute. Statistical analysis system, ver. 6.12. Cary, NC, SAS Institute, 1997.
19. Schoenberg J, Beck G, Bouhuys A. Growth and decay of pulmonary function in healthy blacks and whites. Respir Physiol 1978; 33: 367-393.
20. Anderson R, Hamman R, Savage P, et al. Exploration of simple insulin sensitivity measures derived from frequently sampled intravenous glucose tolerance (FSGIT) tests. Am J Epidemiol 1995; 142: 724-732.
21. Laakso M. How good a marker is insulin level for insulin resistance? Am J Epidemiol 1993; 137: 959-965.
22. Cleland SJ, Petrie JR, Morris AD, Ueda S, Dorrian CA, Connell JMC. FIRI: a fair insulin resistance index. Lancet 1996; 347: 770.
23. Del Prato S, Pozzilli P. FIRI: fasting or false insulin resistance index? Lancet 1996; 347: 132.
24. American Thoracic Society. Standardization of spirometry. Am Rev Respir Dis 1979; 119: 831-838.
25. Coleman E, Toth M, Katzel L, Fonong T, Gardner A, Poehlman E. Body fatness and waist circumference are independent predictors of the age-associated increase in fasting insulin levels in healthy men and women. Int J Obesity 1995; 19: 798-803.
26. Bjorntorp P. The regulation of adipose tissue distribution in humans. Int J Obesity 1996; 20: 291-302.
27. Collins L, Hoberty P, Walker J, Fletcher E, Peiris A. The effect of body fat distribution on pulmonary function tests. Chest 1995; 107: 1298-1302.
28. Lazarus R, Sparrow D, Weiss ST. Effects of obesity and fat distribution on ventilatory function. Chest 1997; 111: 891-898.
29. Lazarus R, Gore C, Booth M, Owen N. Effects of body composition and fat distribution on ventilatory function in adults. Am J Clin Nutr 1998; 68: 35-41.
30. Lazarus R, Sparrow D, Weiss ST. Hand grip strength and insulin levels: cross sectional and longitudinal associations in the Normative Aging Study. Metabolism 1997; 46: 1266-1269.
31. Laakso M, Edelman SV, Brechtel G, Baron AD. Decreased effect of insulin to simulate skeletal blood flow in obese man: a novel mechanism for insulin resistance. J Clin Invest 1990; 85: 1844-1852.
32. Perry I, Wannarnethee SG, Whincup P, Shaper AG, Walker M, Alberti KG. Serum insulin and incident coronary heart disease in middle-aged British men. Am J Epidemiol 1996; 144: 224-234.